Old Web
English
Sign In
Acemap
>
Paper
>
Biosimilars in Rheumatic Diseases: Regulatory Guidelines, Efficacy and Safety Implications in Saudi Arabia
Biosimilars in Rheumatic Diseases: Regulatory Guidelines, Efficacy and Safety Implications in Saudi Arabia
2018
Hussein Halabi
Zeyad Al Zahrani
Ramiz Al Swailem
Waleed Husain
Hanan Al-Rayes
Hanan Al-Osaimi
Yasser El Dershaby
Haytham Mohamed Ahmed
Mohamed Mounir
Mohammed A. Omair
Keywords:
Biosimilar
Physical therapy
Rheumatology
Pharmacology
Internal medicine
Medicine
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
32
References
3
Citations
NaN
KQI
[]